Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
See the top stocks recommended by analysts >>
Read More on IMVT:
- Immunovant Announces Proposed Offering of $300 Million of Common Stock
- Immunovant (NASDAQ: IMVT) Surges after Remarkable Drug Results
- Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
- Immunovant to Host Conference Call and Webcast to Report Initial IMVT-1402 Phase 1 Results on September 26, 2023
- Immunovant put volume heavy and directionally bearish